Global Chronic Kidney Disease Drugs Market
Chronic Kidney Disease Drugs Market Size And Forecast
According to Verified Market Research, the Chronic Kidney Disease Drugs Market was valued at USD 12.85 Billion in 2018 and is projected to reach USD 15.8 Billion by 2026, growing at a CAGR of 2.6% from 2019 to 2026.
Global Chronic Kidney Disease Drugs Market Outlook
The global chronic kidney disease (CKD) market is majorly driven by the rising incidence of chronic kidney disease among patients globally. This bolsters the need for novel treatments to improve the quality of life of patients. According to the Centers for Disease Control and Prevention report published in 2019, about 37 million people are estimated to have chronic kidney disease in the United States. Also, increasing the geriatric population, increasing research and development activities in the development of CKD drugs, and favorable reimbursement policies in some countries are some other factors expected to propel the market growth. Moreover, due to the high unmet needs, technological advancements in treatment and innovations are further expected to fuel the market growth. However, increasing inclinations of generic drugs and poor patient compliance in some countries, are expected to hamper the growth of the market.
Global Chronic Kidney Disease Drugs Market Competitive Landscape
The Global Chronic Kidney Disease Drugs Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as AstraZeneca, Pfizer Inc., Amgen Inc., FibroGen, Inc., GlaxoSmithKline plc., F. Hoffmann-La Roche, AbbVie Inc., Akebia Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., and Johnson & Johnson Services, Inc.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.